C07C 235/50
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
C07C235/50 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 85 US grants and 89 published applications in this corpus.
Search patents in C07C- Granted patents
- 85
- Published applications
- 89
- Assignees
- 86
- Inventors
- 366
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 4 | 2 |
| 2004 | 0 | 6 |
| 2005 | 3 | 6 |
| 2006 | 5 | 4 |
| 2007 | 3 | 6 |
| 2008 | 5 | 7 |
| 2009 | 4 | 8 |
| 2010 | 6 | 8 |
| 2011 | 2 | 1 |
| 2012 | 6 | 4 |
| 2013 | 1 | 2 |
| 2014 | 1 | 3 |
| 2015 | 0 | 0 |
| 2016 | 2 | 2 |
| 2017 | 1 | 3 |
| 2018 | 2 | 1 |
| 2019 | 1 | 4 |
| 2020 | 4 | 3 |
| 2021 | 4 | 4 |
| 2022 | 3 | 3 |
| 2023 | 2 | 4 |
| 2024 | 2 | 0 |
| 2025 | 1 | 5 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydroxybenzamide derivatives and methods of use in treating diabetes30 Dec 2025US 12,509,429 B2The Board of Regents of the University of Oklahoma
- Compound containing diphenylmethane structure and use thereof24 Dec 2024US 12,172,946 B2Guangzhou Trojan Pharmatec Ltd.
- Ketone inhibitors of lysine gingipain8 Oct 2024US 12,110,263 B2Lighthouse Pharmaceuticals, Inc.
- Retinoid derivatives with antitumor activity21 Nov 2023US 11,819,484 B2Biogem S.C. A R.L.
- Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers10 Jan 2023US 11,548,894 B2Board of Regents, The University of Texas System
- Biphenyl compound, pharmaceutical composition, method for preparing same, and use thereof1 Oct 2026US 2026/0297017 A1Longivitron (Suzhou) Biotechnology Co., Ltd
- Fluorine-containing compound30 Oct 2025US 2025/0333902 A1Daikin Industries, Ltd.
- Ketone inhibitors of lysine gingipain28 Aug 2025US 2025/0270162 A1Lighthouse Pharmaceuticals, Inc.
- Novel cannabinoid derivatives24 Jul 2025US 2025/0236578 A1Cannasoul Analytics Ltd.
- Anisamide-containing lipids and compositions and methods of use thereof24 Apr 2025US 2025/0127719 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla60US 7,067,665 B2Sanofi-Aventis Deutschland GmbH · 2006
- N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives56US 7,176,242 B2Elan Pharmaceuticals, Inc. · 2007
- Oxybenzamide derivatives useful for inhibiting factor Xa or viia53US 6,953,857 B2Aventis Pharma Deutschland GmbH · 2005
- Compounds and pharmaceutical use thereof44US 6,017,919 AJapan Tobacco Inc. · 2000
- Melanin concentrating hormone antagonist34US 7,115,750 B1Takeda Pharmaceutical Company Limited · 2006